Regional Monitoring EECA
by ECUO PLWH
Regional Monitoring EECA
Showing 1-876 of 876 items.
| # | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Republic of Poland | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 72.5 | 100 | 1 | 72.5 | 100 | 7250 | 2015 | Not specified | Not specified | Not specified | |||
| 2 | Russian Federation | Government | Pharmasyntez | Olitid | Abacavir (ABC) | 300mg tab | 1.1333 | 2643840 | 60 | 68 | 44064 | 2996352 | 2015 | Not specified | Not specified | Not specified | |||
| 3 | Republic of Poland | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 69.39 | 50 | 1 | 69.39 | 50 | 3469.5 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 4 | Russian Federation | Government | Pharmasyntez | Olitid | Abacavir (ABC) | 300mg tab | 0.3 | 1472460 | 60 | 18 | 24541 | 441738 | 2016 | Yes | Yes | Not specified | |||
| 5 | Republic of Kazakhstan | Government | MYLAN LABORATORIES LTD | Abacavir (ABC) | 300mg tab | 0.043 | 11091600 | 60 | 2.58 | 184860 | 476938.81 | 2015 | Not specified | Not specified | Not specified | ||||
| 6 | Republic of Poland | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 69.39 | 100 | 1 | 69.39 | 100 | 6939 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 7 | Russian Federation | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 300mg tab | 1.0932 | 820920 | 60 | 65.59 | 13682 | 897402.38 | 2015 | Not specified | Not specified | Not specified | |||
| 8 | Republic of Poland | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 72.5 | 44 | 1 | 72.5 | 44 | 3190 | 2015 | Not specified | Not specified | Not specified | |||
| 9 | Republic of Latvia | Government | Viiv Healthcare UK Limited | Ziagen | Abacavir (ABC) | 300mg tab | 3.9867 | 38400 | 60 | 239.2 | 640 | 153088 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 10 | Ukraine | Global Fund | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 300mg tab | 0.4037 | 1175040 | 60 | 24.22 | 19584 | 474324.47 | 2016 | Yes | Yes | Not specified | |||
| 11 | Republic of Belarus | Global Fund | GlaxoSmithKline | Abacavir (ABC) | 20mg/ml oral solution 240ml | 14.99 | 165 | 1 | 14.99 | 165 | 2473.35 | UNDP/UNICEF | 2016 | Yes | No | Not specified | |||
| 12 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir | Abacavir (ABC) | 300mg tab | 0.1848 | 60 | 60 | 11.09 | 1 | 11.09 | 2016 | Yes | Yes | Yes | |||
| 13 | Republic of Tajikistan | Global Fund | ViiV Healthcare | Abacavir (ABC) | 20mg/ml oral solution 240ml | 8 | - | 1 | 8 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 14 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 300mg tab | 0.1917 | 18000 | 60 | 11.5 | 300 | 3450 | UNDP/UNICEF | 2016 | Not specified | Yes | Not specified | |||
| 15 | Russian Federation | Government | R-Farm | Abacavir | Abacavir (ABC) | 300mg tab | 0.274 | 631080 | 60 | 16.44 | 10518 | 172915.92 | 2016 | Yes | Yes | Not specified | |||
| 16 | Republic of Poland | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 72.5 | 40 | 1 | 72.5 | 40 | 2900 | 2015 | Not specified | Not specified | Not specified | |||
| 17 | Republic of Kazakhstan | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 300mg tab | 0.0283 | 60 | 60 | 1.7 | 1 | 1.7 | 2016 | Yes | Yes | Not specified | |||
| 18 | Kyrgyz Republic | Global Fund | Hetero labs Ltd. | Abacavir (ABC) | 300mg tab | 0.2125 | 21180 | 60 | 12.75 | 353 | 4500.75 | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 19 | Republiс of Azerbaijan | Government | GlaxoSmithKline | Abacavir (ABC) | 300mg tab | 0.6048 | 28560 | 60 | 36.29 | 476 | 17274.04 | 2015 | Yes | Yes | Not specified | ||||
| 20 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 300mg tab | 0.1848 | 60 | 60 | 11.09 | 1 | 11.09 | 2015 | Not specified | Not specified | Not specified | ||||
| 21 | Republic of Kazakhstan | Government | Abdi Ibrahim Global Farm | Virakar | Abacavir (ABC) | 300mg tab | 0.0322 | 60 | 60 | 1.93 | 1 | 1.93 | 2016 | Yes | Not specified | Not specified | |||
| 22 | Georgia | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 6.83 | 45 | 1 | 6.83 | 45 | 307.35 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | |||
| 23 | Republic of Poland | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 69.39 | 50 | 1 | 69.39 | 50 | 3469.5 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 24 | Republiс of Azerbaijan | Government | Aurobindo Pharma Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 37.44 | 533 | 1 | 37.44 | 533 | 19955.52 | 2015 | Yes | Yes | Not specified | ||||
| 25 | Russian Federation | Government | Drugs technology | Abacavir-ABC | Abacavir (ABC) | 300mg tab | 1.159 | 6552120 | 60 | 69.54 | 109202 | 7593907 | 2015 | Not specified | Not specified | Not specified | |||
| 26 | Republic of Belarus | Government | Hetero Labs + Фарматех | Abacavir | Abacavir (ABC) | 300mg tab | 0.3667 | 900840 | 60 | 22 | 15014 | 330308 | Republican unitary enterprise "BELPHARMATSIYA" | 2016-02-18 | Yes | Yes | No | ||
| 27 | Ukraine | Government | MYLAN LABORATORIES LTD | Abacavir (ABC) | Abacavir (ABC) | 300mg tab | 0.1782 | 813240 | 60 | 10.69 | 13554 | 144892.27 | 2016 | Yes | Yes | Not specified | |||
| 28 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 10.5 | 1044 | 1 | 10.5 | 1044 | 10962 | UNDP/UNICEF | 2016 | Not specified | Yes | Not specified | |||
| 29 | Russian Federation | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 36.8 | 659 | 1 | 36.8 | 659 | 24251.2 | 2016 | Yes | Yes | Not specified | |||
| 30 | Republic of Kazakhstan | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 300mg tab | 0.044 | 2343600 | 60 | 2.64 | 39060 | 103118.4 | 2015 | Not specified | Not specified | Not specified | |||
| 31 | Republic of Latvia | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 300mg tab | 3.4702 | 60 | 60 | 208.21 | 1 | 208.21 | 2015 | Not specified | Not specified | Not specified | |||
| 32 | Ukraine | Government | ViiV Healthcare | Abacavir (ABC) | 20mg/ml oral solution 240ml | 0.08 | 1191015 | 1 | 0.08 | 1191015 | 95281.2 | 2015 | Not specified | Not specified | Not specified | ||||
| 33 | Republic of Poland | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 300mg tab | 3.8125 | 39000 | 60 | 228.75 | 650 | 148687.5 | 2015 | Not specified | Not specified | Not specified | |||
| 34 | Republic of Moldova | Government | Viiv Healthcare UK Limited | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 59.98 | 114 | 1 | 59.98 | 114 | 6837.72 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Not specified | ||
| 35 | Republic of Belarus | Global Fund | Hetero labs Ltd. | Abacavir (ABC) | 300mg tab | 0.1848 | 299100 | 60 | 11.09 | 4985 | 55283.65 | UNICEF Supply Division | 2015 | 2015-05-24 | Not specified | Not specified | Not specified | ||
| 36 | Russian Federation | Government | Pharmasyntez | Olitid | Abacavir (ABC) | 150mg tab | 0.6933 | 18060 | 60 | 41.6 | 301 | 12521.6 | 2015 | Not specified | Not specified | Not specified | |||
| 37 | Ukraine | PEPFAR | MYLAN LABORATORIES LTD | Abacavir (ABC) | Abacavir (ABC) | 300mg tab | 0.154 | 563040 | 60 | 9.24 | 9384 | 86708.16 | 2016 | Yes | Not specified | Not specified | |||
| 38 | Georgia | Global Fund | Hetero labs Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 7.5 | 216 | 1 | 7.5 | 216 | 1620 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 39 | Republic of Latvia | Government | Viiv Healthcare UK Limited | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 82.62 | 82 | 1 | 82.62 | 82 | 6774.84 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 40 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir | Abacavir (ABC) | 20mg/ml oral solution 240ml | 12 | 1 | 1 | 12 | 1 | 12 | 2016 | Yes | Yes | Yes | |||
| 41 | Republic of Poland | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 150mg tab | 3.4667 | 30000 | 60 | 208 | 500 | 104000 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 42 | Russian Federation | Government | Pharmasyntez | Olitid | Abacavir (ABC) | 300mg tab | 0.498 | 167820 | 60 | 29.88 | 2797 | 83574.36 | 2016 | Yes | Yes | Not specified | |||
| 43 | Republic of Armenia | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 6.75 | 2 | 1 | 6.75 | 2 | 13.5 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 44 | Republic of Poland | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 300mg tab | 3.3627 | 18000 | 60 | 201.76 | 300 | 60528 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 45 | Georgia | Global Fund | MYLAN LABORATORIES LTD | Abacavir (ABC) | 300mg tab | 0.1832 | 12960 | 60 | 10.99 | 216 | 2373.84 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 46 | Republic of Poland | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 300mg tab | 3.8125 | 3000 | 60 | 228.75 | 50 | 11437.5 | 2015 | Not specified | Not specified | Not specified | |||
| 47 | Ukraine | Global Fund | GlaxoSmithKline | Abacavir (ABC) | 300mg tab | 0.425 | 60 | 60 | 25.5 | 1 | 25.5 | 2015 | Not specified | Not specified | Not specified | ||||
| 48 | Russian Federation | Government | Pharmasyntez | Olitid | Abacavir (ABC) | 600mg tab | 2.5097 | 6022320 | 30 | 75.29 | 200744 | 15114016 | 2015 | Not specified | Not specified | Not specified | |||
| 49 | Republic of Poland | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 300mg tab | 3.8125 | 30000 | 60 | 228.75 | 500 | 114375 | 2015 | Not specified | Not specified | Not specified | |||
| 50 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 12 | - | 1 | 12 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 51 | Republic of Armenia | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 300mg tab | 0.1817 | 1740 | 60 | 10.9 | 29 | 316.1 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 52 | Republic of Kazakhstan | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 71.2 | 1 | 1 | 71.2 | 1 | 71.2 | 2016 | Yes | Not specified | Not specified | |||
| 53 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 300mg tab | 0.2333 | 60 | 60 | 14 | 1 | 14 | 2015 | Not specified | Not specified | Not specified | ||||
| 54 | Kyrgyz Republic | Global Fund | Hetero labs Ltd. | Abacavir (ABC) | 300mg tab | 0.1653 | 38700 | 60 | 9.92 | 645 | 6398.4 | UNDP/UNICEF | 2016 | No | No | Not specified | |||
| 55 | Russian Federation | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 45.6 | 21875 | 1 | 45.6 | 21875 | 997500 | 2015 | Not specified | Not specified | Not specified | |||
| 56 | Republic of Belarus | Government | Hetero Labs + Фарматех | Abacavir (ABC) | 300mg tab | 0.3342 | 900840 | 60 | 20.05 | 15014 | 301030.69 | Фарматех ЗАО | 2015 | Not specified | Not specified | Not specified | |||
| 57 | Ukraine | Government | Hetero labs Ltd. | Abacavir | Abacavir (ABC) | 20mg/ml oral solution 240ml | 9.15 | 4963 | 1 | 9.15 | 4963 | 45411.45 | 2016 | Yes | Yes | Yes | |||
| 58 | Russian Federation | Government | Pharmasyntez | Olitid | Abacavir (ABC) | 600mg tab | 1.2 | 1675950 | 30 | 36 | 55865 | 2011140 | 2016 | Not specified | Yes | Not specified | |||
| 59 | Republic of Kazakhstan | Government | Kievmedpreparat, Ukraine | Abacavir (ABC) | 20mg/ml oral solution 240ml | 119.48 | 596 | 1 | 119.48 | 596 | 71210.08 | 2015 | Not specified | Not specified | Not specified | ||||
| 60 | Republic of Latvia | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 66.29 | - | 1 | 66.29 | - | - | 2015 | Not specified | Not specified | Not specified | |||
| 61 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Abacavir (ABC) | 300mg tab | 0.1665 | 420 | 60 | 9.99 | 7 | 69.93 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 62 | Republic of Armenia | Global Fund | Cipla Ltd | Abacavir (ABC) | 300mg tab | 0.195 | 6900 | 60 | 11.7 | 115 | 1345.5 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 63 | Ukraine | Government | GlaxoSmithKline | Abacavir (ABC) | 300mg tab | 0.2682 | 813240 | 60 | 16.09 | 13554 | 218083.86 | 2015 | Not specified | Not specified | Not specified | ||||
| 64 | Ukraine | PEPFAR | MYLAN LABORATORIES LTD | Abacavir (ABC) | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.3733 | 966480 | 30 | 11.2 | 32216 | 360819.19 | 2016 | Yes | Not specified | Not specified | |||
| 65 | Republic of Latvia | Government | Viiv Healthcare UK Limited | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 13.188 | 197760 | 30 | 395.64 | 6592 | 2608059 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 66 | Russian Federation | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 1.8 | 36000 | 30 | 54 | 1200 | 64800 | 2016 | Yes | Yes | Not specified | |||
| 67 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir+Lamivudine - FDC | 60mg+30mg tab | 0.0833 | 248400 | 60 | 5 | 4140 | 20700 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 68 | Ukraine | Government | Cipla Ltd | Abacavir+Lamivudine - FDC | 60mg+30mg tab | 0.0972 | 64440 | 60 | 5.83 | 1074 | 6261.42 | 2015 | Not specified | Not specified | Not specified | ||||
| 69 | Republic of Moldova | Global Fund | MYLAN LABORATORIES LTD | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.565 | 10110 | 30 | 16.95 | 337 | 5712.15 | IDA Foundation | 2016 | Not specified | Not specified | Not specified | |||
| 70 | Russian Federation | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 4.002 | 4361970 | 30 | 120.06 | 145399 | 17456604 | 2015 | Not specified | Not specified | Not specified | |||
| 71 | Republic of Moldova | Government | Viiv Healthcare UK Limited | Ziagen | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 5.8167 | 24870 | 30 | 174.5 | 829 | 144660.5 | Dita Estfarm SRL | Not specified | Not specified | Not specified | |||
| 72 | Ukraine | Government | GlaxoSmithKline | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.9797 | 171930 | 30 | 29.39 | 5731 | 168434.09 | 2015 | Not specified | Not specified | Not specified | ||||
| 73 | Georgia | Global Fund | MYLAN LABORATORIES LTD | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4163 | 26370 | 30 | 12.49 | 879 | 10978.71 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | |||
| 74 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.565 | 5040 | 30 | 16.95 | 168 | 2847.6 | 2015 | Not specified | Yes | Not specified | ||||
| 75 | Republic of Lithuania | Insurance Fund | Viiv Healthcare UK Limited | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 7.5193 | 30 | 30 | 225.58 | 1 | 225.58 | 2016 | Yes | Yes | Not specified | |||
| 76 | Republic of Tajikistan | Global Fund | ViiV Healthcare | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.5167 | 30 | 30 | 15.5 | 1 | 15.5 | 2015 | Not specified | Not specified | Not specified | ||||
| 77 | Ukraine | Global Fund | GlaxoSmithKline | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 1.02 | 30 | 30 | 30.6 | 1 | 30.6 | 2015 | Not specified | Not specified | Not specified | ||||
| 78 | Ukraine | Government | Aurobindo Pharma Ltd. | Abacavir+Lamivudim | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4043 | 171930 | 30 | 12.13 | 5731 | 69517.03 | 2016 | Yes | Yes | Yes | |||
| 79 | Republic of Kazakhstan | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.3777 | 3047400 | 30 | 11.33 | 101580 | 1150901.38 | 2015 | Not specified | Not specified | Not specified | |||
| 80 | Republic of Moldova | Global Fund | Cipla Ltd | Abacavir+Lamivudine - FDC | 60mg+30mg tab | 0.12 | 21480 | 60 | 7.2 | 358 | 2577.6 | 2015 | Not specified | Yes | Not specified | ||||
| 81 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4163 | 8220 | 30 | 12.49 | 274 | 3422.26 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 82 | Republic of Poland | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 14.1667 | 195000 | 30 | 425 | 6500 | 2762500 | 2015 | Not specified | Not specified | Not specified | |||
| 83 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.565 | 5070 | 30 | 16.95 | 169 | 2864.55 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 84 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4333 | 1590 | 30 | 13 | 53 | 689 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 85 | Republic of Latvia | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 11.619 | 30 | 30 | 348.57 | 1 | 348.57 | 2015 | Not specified | Not specified | Not specified | |||
| 86 | Republic of Moldova | Global Fund | Aurobindo Pharma Ltd. | Abacavir+Lamivudine - FDC | 60mg+30mg tab | 0.12 | 44460 | 60 | 7.2 | 741 | 5335.2 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 87 | Republic of Poland | Government | Sandoz | Abacavir + Lamivudine Sandoz | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 8.3753 | 51000 | 30 | 251.26 | 1700 | 427142 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 88 | Republic of Poland | Government | Viiv Healthcare UK Limited | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 14.1667 | 18000 | 30 | 425 | 600 | 255000 | 2015 | Not specified | Not specified | Not specified | |||
| 89 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4667 | 90000 | 30 | 14 | 3000 | 42000 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 90 | Republic of Poland | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 14.1667 | 66000 | 30 | 425 | 2200 | 935000 | 2015 | Not specified | Not specified | Not specified | |||
| 91 | Kyrgyz Republic | Global Fund | Aurobindo Pharma Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.5167 | - | 30 | 15.5 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 92 | Republic of Moldova | Global Fund | Cipla Ltd | Abacavir+Lamivudine - FDC | 60mg+30mg tab | 0.12 | 21060 | 60 | 7.2 | 351 | 2527.2 | 2015 | Not specified | Yes | Not specified | ||||
| 93 | Republic of Moldova | Government | Ranbaxy Laboratories Limited | Abacavir+Lamivudine - FDC | 60mg+30mg tab | 0.1843 | 55740 | 30 | 5.53 | 1858 | 10274.74 | Medeferent Grup SRL | Not specified | Not specified | Not specified | ||||
| 94 | Republic of Kazakhstan | Government | Aurobindo Pharma Ltd. | Abacavir+Lamivudim | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.06 | 30 | 30 | 1.8 | 1 | 1.8 | 2016 | Yes | Not specified | Yes | |||
| 95 | Republic of Tajikistan | Global Fund | ViiV Healthcare | Abacavir+Lamivudine - FDC | 60mg+30mg tab | 0.0833 | 60 | 60 | 5 | 1 | 5 | 2015 | Not specified | Not specified | Not specified | ||||
| 96 | Ukraine | Global Fund | GlaxoSmithKline | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.969 | 629100 | 30 | 29.07 | 20970 | 609597.88 | 2016 | Yes | Yes | Not specified | |||
| 97 | Georgia | Global Fund | GlaxoSmithKline | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 1.9667 | 49440 | 30 | 59 | 1648 | 97232 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | |||
| 98 | Republic of Poland | Government | GlaxoSmithKline | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 12.882 | 138000 | 30 | 386.46 | 4600 | 1777716 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 99 | Republiс of Azerbaijan | Government | ViiV Healthcare | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 1.7167 | 21960 | 30 | 51.5 | 732 | 37698 | 2015 | Yes | Yes | Not specified | ||||
| 100 | Republic of Lithuania | Insurance Fund | Teva BV | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 7.5747 | 30 | 30 | 227.24 | 1 | 227.24 | 2016 | Yes | Yes | Yes | |||
| 101 | Republic of Poland | Government | GlaxoSmithKline | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 12.882 | 3000 | 30 | 386.46 | 100 | 38646 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 102 | Kyrgyz Republic | Global Fund | Cipla Ltd | Abamune-L Baby | Abacavir+Lamivudine - FDC | 60mg+30mg tab | 0.0833 | 2820 | 60 | 5 | 47 | 235 | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified |
| 103 | Republic of Lithuania | Government | Viiv Healthcare UK Limited | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 11.1373 | 30 | 30 | 334.12 | 1 | 334.12 | Viiv Healthcare UK Limited | 2015 | Not specified | Yes | Not specified | ||
| 104 | Republic of Poland | Government | GlaxoSmithKline | Trizivir | Abacavir+Lamivudine+Zidovudine - FDC | 300mg+150mg+300mg tab | 9.3723 | 1800 | 60 | 562.34 | 30 | 16870.2 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 105 | Republic of Kazakhstan | Government | GlaxoSmithKline | Trizivir | Abacavir+Lamivudine+Zidovudine - FDC | 300mg+150mg+300mg tab | 0.0633 | 60 | 60 | 3.8 | 1 | 3.8 | 2016 | Not specified | Yes | Not specified | |||
| 106 | Republic of Poland | Government | ViiV Healthcare | Trizivir | Abacavir+Lamivudine+Zidovudine - FDC | 300mg+150mg+300mg tab | 9.7917 | 900 | 60 | 587.5 | 15 | 8812.5 | 2015 | Not specified | Not specified | Not specified | |||
| 107 | Republic of Kazakhstan | Government | ViiV Healthcare | Abacavir+Lamivudine+Zidovudine - FDC | 300mg+150mg+300mg tab | 0.1078 | 3877200 | 60 | 6.47 | 64620 | 418091.41 | 2015 | Not specified | Not specified | Not specified | ||||
| 108 | Republic of Kazakhstan | Government | ViiV Healthcare | Abacavir+Lamivudine+Zidovudine - FDC | 300mg+150mg+300mg tab | 0.1078 | 3600 | 60 | 6.47 | 60 | 388.2 | 2015 | Not specified | Not specified | Not specified | ||||
| 109 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 150mg caps | 6.8198 | 6600 | 60 | 409.19 | 110 | 45010.9 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 110 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 2.137 | 1038960 | 60 | 128.22 | 17316 | 2220257.5 | 2016 | Yes | Yes | Not specified | |||
| 111 | Republic of Latvia | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 13.0957 | 30 | 30 | 392.87 | 1 | 392.87 | 2015 | Not specified | Not specified | Not specified | |||
| 112 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 2.137 | 692640 | 60 | 128.22 | 11544 | 1480171.62 | 2016 | Yes | Yes | Not specified | |||
| 113 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 7.5 | 13800 | 60 | 450 | 230 | 103500 | 2015 | Not specified | Not specified | Not specified | |||
| 114 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 3.603 | 111030 | 30 | 108.09 | 3701 | 400041.09 | 2015 | Not specified | Not specified | Not specified | |||
| 115 | Republic of Belarus | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir (ATV) | 300mg caps | 0.5667 | 4320 | 30 | 17 | 144 | 2448 | IDA Foundation | 2015 | 2015-12-22 | 2016-04-14 | No | No | Not specified | |
| 116 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 6.6152 | 3000 | 60 | 396.91 | 50 | 19845.5 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 117 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 150mg caps | 1.7975 | 5537820 | 60 | 107.85 | 92297 | 9954231 | 2015 | Not specified | Not specified | Not specified | |||
| 118 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 15.4167 | 3000 | 30 | 462.5 | 100 | 46250 | 2015 | Not specified | Not specified | Not specified | |||
| 119 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 15.4167 | 27000 | 30 | 462.5 | 900 | 416250 | 2015 | Not specified | Not specified | Not specified | |||
| 120 | Republic of Belarus | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir (ATV) | 300mg caps | 0.5667 | 15630 | 30 | 17 | 521 | 8857 | UNDP/UNICEF | 2016 | No | No | Not specified | |||
| 121 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 14.0183 | 72000 | 30 | 420.55 | 2400 | 1009320 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 122 | Republic of Latvia | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 14.8337 | 67260 | 30 | 445.01 | 2242 | 997712.44 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 123 | Republic of Moldova | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir (ATV) | 300mg caps | 0.6983 | 5010 | 30 | 20.95 | 167 | 3498.65 | IDA Foundation | 2016 | Not specified | Not specified | Not specified | |||
| 124 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 1.6 | 511500 | 60 | 96 | 8525 | 818400 | 2016 | Yes | Yes | Not specified | |||
| 125 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 15.4167 | 162000 | 30 | 462.5 | 5400 | 2497500 | 2015 | Not specified | Not specified | Not specified | |||
| 126 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 150mg caps | 1.6 | 341100 | 60 | 96 | 5685 | 545760 | 2016 | Yes | Yes | Not specified | |||
| 127 | Georgia | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir (ATV) | 300mg caps | 0.6 | 48600 | 30 | 18 | 1620 | 29160 | partnership for supply. chain management (PFSCM) | 2015 | No | Yes | Not specified | |||
| 128 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 11.6297 | 18000 | 30 | 348.89 | 600 | 209334 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 129 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 2.3747 | 10007940 | 60 | 142.48 | 166799 | 23765522 | 2015 | Not specified | Not specified | Not specified | |||
| 130 | Republic of Moldova | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir (ATV) | 300mg caps | 0.6983 | 5010 | 30 | 20.95 | 167 | 3498.65 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 131 | Republic of Poland | Government | Bristol-Myers Squibb | Evotaz | Atazanavir+Cobicistat | 300mg+150mg tab | 14.7763 | 69000 | 30 | 443.29 | 2300 | 1019567 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 132 | Republic of Poland | Government | Bristol-Myers Squibb | Evotaz | Atazanavir+Cobicistat | 300mg+150mg tab | 14.333 | 900 | 30 | 429.99 | 30 | 12899.7 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 133 | Republic of Poland | Government | Bristol-Myers Squibb | Evotaz | Atazanavir+Cobicistat | 300mg+150mg tab | 16.25 | 36000 | 30 | 487.5 | 1200 | 585000 | 2015 | Not specified | Not specified | Not specified | |||
| 134 | Republic of Armenia | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir+Ritonavir - FDC | 300mg+100mg tab | 0.55 | 4320 | 30 | 16.5 | 144 | 2376 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 135 | Republic of Armenia | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir+Ritonavir - FDC | 300mg+100mg tab | 0.55 | 3870 | 30 | 16.5 | 129 | 2128.5 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 136 | Republic of Tajikistan | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir+Ritonavir - FDC | 300mg+100mg tab | 0.55 | 20160 | 30 | 16.5 | 672 | 11088 | UNDP/UNICEF | Not specified | Not specified | Not specified | ||||
| 137 | Georgia | Global Fund | MYLAN LABORATORIES LTD | Atazanavir+Ritonavir - FDC | 300mg+100mg tab | 0.55 | 58800 | 30 | 16.5 | 1960 | 32340 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | |||
| 138 | Republiс of Azerbaijan | Government | Cipla Ltd | Atazanavir+Ritonavir - FDC | 300mg+100mg tab | 2.2367 | 5040 | 30 | 67.1 | 168 | 11272.8 | 2015 | Yes | Yes | Not specified | ||||
| 139 | Republic of Kazakhstan | Government | Janssen | Prezista | Darunavir (TCM) | 600mg tab | 0.11 | 60 | 60 | 6.6 | 1 | 6.6 | 2016 | Yes | Not specified | Not specified | |||
| 140 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 600mg tab | 10.0227 | 42000 | 60 | 601.36 | 700 | 420952 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 141 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 600mg tab | 11.025 | 87000 | 60 | 661.5 | 1450 | 959175 | 2015 | Not specified | Not specified | Not specified | |||
| 142 | Russian Federation | Government | Janssen | Prezista | Darunavir (TCM) | 400mg tab | 5.043 | 3180 | 60 | 302.58 | 53 | 16036.74 | 2015 | Not specified | Not specified | Not specified | |||
| 143 | Ukraine | Government | Janssen | Darunavir (TCM) | 400mg tab | 5.7 | 2220 | 60 | 342 | 37 | 12654 | 2015 | Not specified | Not specified | Not specified | ||||
| 144 | Republiс of Azerbaijan | Government | Janssen | Prezista | Darunavir (TCM) | 600mg tab | 20.5662 | 11520 | 60 | 1233.97 | 192 | 236922.23 | 2015 | Yes | Yes | Not specified | |||
| 145 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 150mg tab | 2.6382 | 2400 | 240 | 633.16 | 10 | 6331.6 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 146 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Darunavir (TCM) | 600mg tab | 1.8202 | 7260 | 60 | 109.21 | 121 | 13214.41 | 2015 | Not specified | Not specified | Not specified | ||||
| 147 | Georgia | Global Fund | Janssen | Darunavir (TCM) | 600mg tab | 11.6 | 13680 | 60 | 696 | 228 | 158688 | partnership for supply. chain management (PFSCM) | 2015 | No | Yes | Not specified | |||
| 148 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 800mg tab | 13.788 | 76500 | 30 | 413.64 | 2550 | 1054782 | 2015 | Not specified | Not specified | Not specified | |||
| 149 | Republic of Belarus | Government | Hetero Labs + Фарматех | Darunavir (TCM) | 600mg tab | 6.9813 | 31680 | 60 | 418.88 | 528 | 221168.64 | Фарматех ЗАО | 2015 | Not specified | Not specified | Not specified | |||
| 150 | Republic of Latvia | Government | Janssen | Prezista | Darunavir (TCM) | 600mg tab | 10.3553 | 60 | 60 | 621.32 | 1 | 621.32 | 2015 | Not specified | Not specified | Not specified | |||
| 151 | Russian Federation | Government | Pharmasyntez | Kemeruvir | Darunavir (TCM) | 600mg tab | 3.88 | 338100 | 60 | 232.8 | 5635 | 1311828 | 2016 | Yes | Yes | Not specified | |||
| 152 | Ukraine | Government | Janssen | Prezista | Darunavir (TCM) | 400mg tab | 5.3692 | 2220 | 60 | 322.15 | 37 | 11919.55 | 2016 | Yes | Yes | Not specified | |||
| 153 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 800mg tab | 12.1613 | 66000 | 30 | 364.84 | 2200 | 802648 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 154 | Russian Federation | Government | Janssen | Prezista | Darunavir (TCM) | 800mg tab | 10.27 | 1910910 | 30 | 308.1 | 63697 | 19625046 | 2015 | Not specified | Not specified | Not specified | |||
| 155 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 800mg tab | 13.788 | 13650 | 30 | 413.64 | 455 | 188206.2 | 2015 | Not specified | Not specified | Not specified | |||
| 156 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Darunavir (TCM) | 600mg tab | 1.8202 | 8640 | 60 | 109.21 | 144 | 15726.24 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 157 | Republic of Tajikistan | Global Fund | Janssen | Darunavir (TCM) | 600mg tab | 1.275 | 2880 | 60 | 76.5 | 48 | 3672 | UNDP/UNICEF | Not specified | Not specified | Not specified | ||||
| 158 | Republic of Lithuania | Insurance Fund | Janssen-Cilag Internarional NV | Prezista | Darunavir (TCM) | 400mg tab | 7.5533 | 60 | 60 | 453.2 | 1 | 453.2 | 2016 | Yes | Yes | Yes | |||
| 159 | Republic of Latvia | Government | Janssen-Cilag Internarional NV | Prezista | Darunavir (TCM) | 400mg tab | 8.8255 | 38040 | 60 | 529.53 | 634 | 335722.03 | National Health Service (NHC) | 2016 | Not specified | Not specified | Yes | ||
| 160 | Russian Federation | Government | Pharmasyntez | Kemeruvir | Darunavir (TCM) | 600mg tab | 5.85 | 199200 | 60 | 351 | 3320 | 1165320 | 2016 | Yes | Yes | Not specified | |||
| 161 | Russian Federation | Government | Hetero labs Ltd. | Darunavir | Darunavir (TCM) | 600mg tab | 6.5503 | 30540 | 60 | 393.02 | 509 | 200047.19 | 2015 | Not specified | Not specified | Not specified | |||
| 162 | Georgia | Global Fund | Hetero labs Ltd. | Prezista | Darunavir (TCM) | 600mg tab | 1.1667 | 38580 | 60 | 70 | 643 | 45010 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 163 | Republic of Lithuania | Insurance Fund | Janssen-Cilag Internarional NV | Prezista | Darunavir (TCM) | 600mg tab | 11.3278 | 60 | 60 | 679.67 | 1 | 679.67 | 2016 | Yes | Yes | Yes | |||
| 164 | Russian Federation | Government | Pharmasyntez | Kemeruvir | Darunavir (TCM) | 600mg tab | 5.82 | 241860 | 60 | 349.2 | 4031 | 1407625.25 | 2016 | Yes | Yes | Not specified | |||
| 165 | Ukraine | PEPFAR | Janssen | Prezista | Darunavir (TCM) | 400mg tab | 5.0407 | 900 | 60 | 302.44 | 15 | 4536.6 | 2016 | Not specified | Not specified | Not specified | |||
| 166 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 800mg tab | 14.985 | 465000 | 30 | 449.55 | 15500 | 6968025 | 2015 | Not specified | Not specified | Not specified | |||
| 167 | Russian Federation | Government | Pharmasyntez | Kemeruvir | Darunavir (TCM) | 400mg tab | 4.6042 | 784380 | 60 | 276.25 | 13073 | 3611416.25 | 2015 | Not specified | Not specified | Not specified | |||
| 168 | Republic of Armenia | Global Fund | Hetero labs Ltd. | Darunavir (TCM) | 600mg tab | 1.1667 | 360 | 60 | 70 | 6 | 420 | partnership for supply. chain management (PFSCM) | 2016 | No | No | Not specified | |||
| 169 | Republic of Armenia | Global Fund | Janssen | Prezista | Darunavir (TCM) | 600mg tab | 11.6 | 300 | 60 | 696 | 5 | 3480 | partnership for supply. chain management (PFSCM) | 2016 | Yes | No | Not specified | ||
| 170 | Republic of Kazakhstan | Government | Janssen | Prezista | Darunavir (TCM) | 400mg tab | 0.0733 | 60 | 60 | 4.4 | 1 | 4.4 | 2016 | Not specified | Not specified | Not specified | |||
| 171 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 800mg tab | 12.5373 | 267000 | 30 | 376.12 | 8900 | 3347468 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 172 | Republic of Armenia | Global Fund | Janssen | Darunavir (TCM) | 600mg tab | 11.6 | 180 | 60 | 696 | 3 | 2088 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 173 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 150mg tab | 2.7563 | 1920 | 240 | 661.5 | 8 | 5292 | 2015 | Not specified | Not specified | Not specified | |||
| 174 | Ukraine | Government | Janssen | Darunavir (TCM) | 600mg tab | 8.55 | 43140 | 60 | 513 | 719 | 368847 | 2015 | Not specified | Not specified | Not specified | ||||
| 175 | Republic of Belarus | Government | Hetero Labs + Фарматех | Darunavir | Darunavir (TCM) | 600mg tab | 7.6 | 31680 | 60 | 456 | 528 | 240768 | Republican unitary enterprise "BELPHARMATSIYA" | 2015 | 2016-02-04 | 2016-03-13 | Yes | Yes | Not specified |
| 176 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 600mg tab | 9.7243 | 18000 | 60 | 583.46 | 300 | 175038 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 177 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Darunavir (TCM) | 600mg tab | 1.8202 | 1380 | 60 | 109.21 | 23 | 2511.83 | 2015 | Not specified | Not specified | Not specified | ||||
| 178 | Republic of Latvia | Government | Janssen | Prezista | Darunavir (TCM) | 400mg tab | 7.8117 | 60 | 60 | 468.7 | 1 | 468.7 | 2015 | Not specified | Not specified | Not specified | |||
| 179 | Russian Federation | Government | Hetero labs Ltd. | Darunavir | Darunavir (TCM) | 600mg tab | 5.85 | 1909980 | 60 | 351 | 31833 | 11173383 | 2016 | Yes | Yes | Not specified | |||
| 180 | Ukraine | Government | Janssen | Prezista | Darunavir (TCM) | 600mg tab | 8.0537 | 43140 | 60 | 483.22 | 719 | 347435.19 | 2016 | Yes | Yes | Not specified | |||
| 181 | Russian Federation | Government | Pharmasyntez | Kemeruvir | Darunavir (TCM) | 600mg tab | 6.8323 | 2157540 | 60 | 409.94 | 35959 | 14741032 | 2015 | Not specified | Not specified | Not specified | |||
| 182 | Republic of Lithuania | Insurance Fund | Janssen-Cilag Internarional NV | Prezista | Darunavir (TCM) | 800mg tab | 15.1067 | 30 | 30 | 453.2 | 1 | 453.2 | 2016 | Yes | Yes | Yes | |||
| 183 | Republic of Latvia | Government | Janssen-Cilag Internarional NV | Prezista | Darunavir (TCM) | 600mg tab | 11.6655 | 4680 | 60 | 699.93 | 78 | 54594.54 | National Health Service (NHC) | 2016 | Not specified | Not specified | Yes | ||
| 184 | Russian Federation | Government | Pharmasyntez | Kemeruvir | Darunavir (TCM) | 800mg tab | 8.6377 | 15870 | 30 | 259.13 | 529 | 137079.77 | 2015 | Not specified | Not specified | Not specified | |||
| 185 | Russian Federation | Government | Hetero labs Ltd. | Darunavir | Darunavir (TCM) | 400mg tab | 3.86 | 225420 | 60 | 231.6 | 3757 | 870121.19 | 2016 | Yes | Yes | Not specified | |||
| 186 | Ukraine | PEPFAR | Janssen | Prezista | Darunavir (TCM) | 600mg tab | 7.561 | 20520 | 60 | 453.66 | 342 | 155151.72 | 2016 | Yes | Yes | Not specified | |||
| 187 | Russian Federation | Government | Janssen | Prezista | Darunavir (TCM) | 600mg tab | 7.0595 | 444480 | 60 | 423.57 | 7408 | 3137806.5 | 2015 | Not specified | Not specified | Not specified | |||
| 188 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Darunavir (TCM) | 600mg tab | 1.8202 | 17280 | 60 | 109.21 | 288 | 31452.48 | IDA Foundation | 2016 | Not specified | Not specified | Not specified | |||
| 189 | Republic of Poland | Government | Janssen | Rezolsta | Darunavir+Cobicistat | 800mg+150mg tab | 12.8813 | 60000 | 30 | 386.44 | 2000 | 772880 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 190 | Republic of Lithuania | Insurance Fund | Janssen-Cilag Internarional NV | Rezolsta | Darunavir+Cobicistat | 800mg+150mg tab | 18.163 | 30 | 30 | 544.89 | 1 | 544.89 | 2016 | Yes | Yes | Not specified | |||
| 191 | Republic of Latvia | Government | Janssen-Cilag Internarional NV | Rezolsta | Darunavir+Cobicistat | 800mg+150mg tab | 15.6237 | 30 | 30 | 468.71 | 1 | 468.71 | 2015 | Not specified | Not specified | Not specified | |||
| 192 | Republic of Lithuania | Government | Janssen-Cilag Internarional NV | Rezolsta | Darunavir+Cobicistat | 800mg+150mg tab | 17.2987 | 30 | 30 | 518.96 | 1 | 518.96 | 2015 | Not specified | Not specified | Not specified | |||
| 193 | Republic of Poland | Government | Janssen | Rezolsta | Darunavir+Cobicistat | 800mg+150mg tab | 12.8813 | 111000 | 30 | 386.44 | 3700 | 1429828 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 194 | Republic of Poland | Government | Bristol-Myers Squibb | Rezolsta | Darunavir+Cobicistat | 800mg+150mg tab | 14.166 | 66000 | 30 | 424.98 | 2200 | 934956 | 2015 | Not specified | Not specified | Not specified | |||
| 195 | Republic of Latvia | Government | Janssen-Cilag Internarional NV | Rezolsta | Darunavir+Cobicistat | 800mg+150mg tab | 17.6513 | 33720 | 30 | 529.54 | 1124 | 595202.94 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 196 | Republic of Poland | Government | Janssen | Rezolsta | Darunavir+Cobicistat | 800mg+150mg tab | 12.4673 | 235500 | 30 | 374.02 | 7850 | 2936057 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 197 | Republic of Poland | Government | Bristol-Myers Squibb | Rezolsta | Darunavir+Cobicistat | 800mg+150mg tab | 14.166 | 3000 | 30 | 424.98 | 100 | 42498 | 2015 | Not specified | Not specified | Not specified | |||
| 198 | Republic of Armenia | Global Fund | Aurobindo Pharma Ltd. | Didanosine | 250mg caps | 0.4 | 480 | 30 | 12 | 16 | 192 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 199 | Russian Federation | Government | Aurobindo Pharma Ltd. | Didanosine | Didanosine | 400mg caps | 1.392 | 1709850 | 30 | 41.76 | 56995 | 2380111.25 | 2015 | Not specified | Not specified | Not specified | |||
| 200 | Republic of Latvia | Government | Bristol-Myers Squibb | Videx | Didanosine | 400mg caps | 5.6147 | 30 | 30 | 168.44 | 1 | 168.44 | 2015 | Not specified | Not specified | Not specified | |||
| 201 | Republic of Latvia | Government | Bristol-Myers Squibb | Videx | Didanosine | 400mg caps | 6.496 | - | 30 | 194.88 | - | - | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 202 | Russian Federation | Government | Aurobindo Pharma Ltd. | Didanosine | Didanosine | 250mg caps | 1.128 | 515760 | 30 | 33.84 | 17192 | 581777.25 | 2015 | Not specified | Not specified | Not specified | |||
| 203 | Russian Federation | Government | Aurobindo Pharma Ltd. | Didanosine | Didanosine | 400mg caps | 1.2 | 624180 | 30 | 36 | 20806 | 749016 | 2016 | Yes | Yes | Not specified | |||
| 204 | Republic of Kazakhstan | Government | Ranbaxy Laboratories Limited | Didanosine | 100mg tab | 0.0245 | 2826000 | 60 | 1.47 | 47100 | 69237 | 2015 | Not specified | Not specified | Not specified | ||||
| 205 | Russian Federation | Government | Bristol-Myers Squibb | Videx | Didanosine | 125mg caps | 0.9523 | 37920 | 30 | 28.57 | 1264 | 36112.48 | 2015 | Not specified | Not specified | Not specified | |||
| 206 | Russian Federation | Government | Bristol-Myers Squibb | Videx | Didanosine | 125mg caps | 0.84 | 1080 | 30 | 25.2 | 36 | 907.2 | 2016 | Yes | Yes | Not specified | |||
| 207 | Georgia | Global Fund | Aurobindo Pharma Ltd. | Didanosine | 400mg caps | 0.6667 | 1800 | 30 | 20 | 60 | 1200 | partnership for supply. chain management (PFSCM) | 2015 | No | Not specified | Not specified | |||
| 208 | Republic of Armenia | Global Fund | Aurobindo Pharma Ltd. | Didanosine | 400mg caps | 0.7333 | 1890 | 30 | 22 | 63 | 1386 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 209 | Russian Federation | Government | Bristol-Myers Squibb | Videx | Didanosine | 2g powder | 17 | 4372 | 1 | 17 | 4372 | 74324 | 2015 | Not specified | Not specified | Not specified | |||
| 210 | Russian Federation | Government | Bristol-Myers Squibb | Videx | Didanosine | 400mg caps | 1.401 | 1300830 | 30 | 42.03 | 43361 | 1822462.88 | 2015 | Not specified | Not specified | Not specified | |||
| 211 | Republiс of Azerbaijan | Government | Aurobindo Pharma Ltd. | Didanosine | Didanosine | 250mg caps | 0.9503 | 17490 | 30 | 28.51 | 583 | 16621.33 | 2015 | Yes | Yes | Not specified | |||
| 212 | Russian Federation | Government | Bristol-Myers Squibb | Videx | Didanosine | 250mg caps | 1.1287 | 475500 | 30 | 33.86 | 15850 | 536681 | 2015 | Not specified | Not specified | Not specified | |||
| 213 | Russian Federation | Government | Bristol-Myers Squibb | Videx | Didanosine | 250mg caps | 0.97 | 93450 | 30 | 29.1 | 3115 | 90646.5 | 2016 | Not specified | Yes | Not specified | |||
| 214 | Republic of Poland | Government | GlaxoSmithKline | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 15.9867 | 168000 | 30 | 479.6 | 5600 | 2685760 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 215 | Republic of Lithuania | Government | Viiv Healthcare UK Limited | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 24.669 | 30 | 30 | 740.07 | 1 | 740.07 | 2015 | Not specified | Not specified | Not specified | |||
| 216 | Ukraine | Government | Aurobindo Pharma Ltd. | Dolutegravir | Dolutegravir (as sodium salt) | 50mg tab | 0.1903 | 24780 | 30 | 5.71 | 826 | 4716.46 | 2016 | Yes | Yes | Yes | |||
| 217 | Georgia | Global Fund | Aurobindo Pharma Ltd. | Dolutegravir | Dolutegravir (as sodium salt) | 50mg tab | 0.1223 | 18630 | 30 | 3.67 | 621 | 2279.07 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 218 | Republic of Poland | Government | GlaxoSmithKline | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 15.913 | 123000 | 30 | 477.39 | 4100 | 1957299 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 219 | Ukraine | PEPFAR | Aurobindo Pharma Ltd. | Dolutegravir | Dolutegravir (as sodium salt) | 50mg tab | 0.1667 | 3409020 | 30 | 5 | 113634 | 568170 | 2016 | Yes | Yes | Yes | |||
| 220 | Republic of Poland | Government | GlaxoSmithKline | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 15.913 | 75000 | 30 | 477.39 | 2500 | 1193475 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 221 | Republic of Belarus | Global Fund | ViiV Healthcare | Dolutegravir (as sodium salt) | 50mg tab | 5.4333 | 3000 | 30 | 163 | 100 | 16300 | IDA Foundation | 2015 | 2015-12-07 | 2016-05-28 | Not specified | Not specified | Not specified | |
| 222 | Republic of Poland | Government | Viiv Healthcare UK Limited | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 17.5 | 31800 | 30 | 525 | 1060 | 556500 | 2015 | Not specified | Not specified | Not specified | |||
| 223 | Republic of Poland | Government | Viiv Healthcare UK Limited | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 17.5 | 15000 | 30 | 525 | 500 | 262500 | 2015 | Not specified | Not specified | Not specified | |||
| 224 | Ukraine | Government | ViiV Healthcare | Dolutegravir (as sodium salt) | 50mg tab | 6.8357 | 24780 | 30 | 205.07 | 826 | 169387.81 | 2015 | Not specified | Not specified | Not specified | ||||
| 225 | Republic of Lithuania | Insurance Fund | Viiv Healthcare UK Limited | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 25.9023 | 30 | 30 | 777.07 | 1 | 777.07 | 2016 | Yes | Yes | Not specified | |||
| 226 | Republic of Latvia | Government | Viiv Healthcare UK Limited | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 23.3383 | 56310 | 30 | 700.15 | 1877 | 1314181.5 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 227 | Republic of Poland | Government | Viiv Healthcare UK Limited | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 17.5 | 57000 | 30 | 525 | 1900 | 997500 | 2015 | Not specified | Not specified | Not specified | |||
| 228 | Republic of Belarus | Global Fund | ViiV Healthcare | Dolutegravir (as sodium salt) | 50mg tab | 5.4333 | 3000 | 30 | 163 | 100 | 16300 | IDA Foundation | 2015 | 2015-12-07 | 2016-04-19 | Not specified | Not specified | Not specified | |
| 229 | Republic of Belarus | Global Fund | Glaxo Operations UK Limited | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 6.3493 | 6150 | 30 | 190.48 | 205 | 39048.4 | UNDP/UNICEF | 2016 | Yes | No | Yes | ||
| 230 | Russian Federation | Government | GlaxoSmithKline | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 7.53 | 12780 | 30 | 225.9 | 426 | 96233.4 | 2016 | Yes | Yes | Not specified | |||
| 231 | Republic of Latvia | Government | Viiv Healthcare UK Limited | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 20.7263 | 30 | 30 | 621.79 | 1 | 621.79 | 2015 | Not specified | Not specified | Not specified | |||
| 232 | Georgia | Global Fund | Aurobindo Pharma Ltd. | Dolutegravir (as sodium salt) | 50mg tab | 0.1223 | 10170 | 30 | 3.67 | 339 | 1244.13 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | |||
| 233 | Republic of Poland | Government | Viiv Healthcare UK Limited | Tivicay | Dolutegravir (as sodium salt) | 50mg tab | 0.0177 | 60000 | 30 | 0.53 | 2000 | 1060 | 2015 | Not specified | Not specified | Not specified | |||
| 234 | Republic of Poland | Government | Viiv Healthcare UK Limited | TRIUMEQ | Dolutegravir+Abacavir/Lamivudine | 50mg+600mg+300mg tab | 26.1 | 12000 | 30 | 783 | 400 | 313200 | 2015 | Not specified | Not specified | Not specified | |||
| 235 | Republic of Lithuania | Insurance Fund | Viiv Healthcare UK Limited | TRIUMEQ | Dolutegravir+Abacavir/Lamivudine | 50mg+600mg+300mg tab | 33.4213 | 30 | 30 | 1002.64 | 1 | 1002.64 | 2016 | Yes | Yes | Not specified | |||
| 236 | Republic of Latvia | Government | Viiv Healthcare UK Limited | TRIUMEQ | Dolutegravir+Abacavir/Lamivudine | 50mg+600mg+300mg tab | 36.443 | 27630 | 30 | 1093.29 | 921 | 1006920.06 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 237 | Republic of Latvia | Government | Viiv Healthcare UK Limited | TRIUMEQ | Dolutegravir+Abacavir/Lamivudine | 50mg+600mg+300mg tab | 32.484 | 30 | 30 | 974.52 | 1 | 974.52 | 2015 | Not specified | Not specified | Not specified | |||
| 238 | Republic of Poland | Government | GlaxoSmithKline | Triumeq | Dolutegravir+Abacavir/Lamivudine | 50mg+600mg+300mg tab | 23.021 | 126000 | 30 | 690.63 | 4200 | 2900646 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 239 | Republic of Poland | Government | GlaxoSmithKline | Triumeq | Dolutegravir+Abacavir/Lamivudine | 50mg+600mg+300mg tab | 23.733 | 126000 | 30 | 711.99 | 4200 | 2990358 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 240 | Republic of Poland | Government | Viiv Healthcare UK Limited | TRIUMEQ | Dolutegravir+Abacavir/Lamivudine | 50mg+600mg+300mg tab | 26.1 | 13500 | 30 | 783 | 450 | 352350 | 2015 | Not specified | Not specified | Not specified | |||
| 241 | Republic of Poland | Government | Viiv Healthcare UK Limited | TRIUMEQ | Dolutegravir+Abacavir/Lamivudine | 50mg+600mg+300mg tab | 26.1 | 45000 | 30 | 783 | 1500 | 1174500 | 2015 | Not specified | Not specified | Not specified | |||
| 242 | Republic of Uzbekistan | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 90 | 90 | 9.3 | 1 | 9.3 | 2015 | Not specified | Not specified | Not specified | ||||
| 243 | Republic of Moldova | Government | Ranbaxy Laboratories Limited | Aviranz | Efavirenz | 200mg tab | 0.08 | 11250 | 90 | 7.2 | 125 | 900 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Yes | ||
| 244 | Kyrgyz Republic | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 89370 | 90 | 9.3 | 993 | 9234.9 | UNDP/UNICEF | 2016 | No | No | Not specified | |||
| 245 | Republic of Latvia | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 600mg tab | 1.388 | 30 | 30 | 41.64 | 1 | 41.64 | 2015 | Not specified | Not specified | Not specified | |||
| 246 | Republic of Tajikistan | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 90 | 90 | 9.3 | 1 | 9.3 | 2015 | Not specified | Not specified | Not specified | ||||
| 247 | Republiс of Azerbaijan | Government | Strides Arcolab Limited | Efavirenz | 600mg tab | 0.459 | 626400 | 30 | 13.77 | 20880 | 287517.59 | 2015 | Yes | Yes | Not specified | ||||
| 248 | Ukraine | Global Fund | Hetero labs Ltd. | Estiva | Efavirenz | 600mg tab | 0.1023 | 2847240 | 30 | 3.07 | 94908 | 291367.56 | 2016 | Yes | Yes | Not specified | |||
| 249 | Ukraine | Government | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1172 | 92430 | 90 | 10.55 | 1027 | 10834.85 | 2015 | Not specified | Not specified | Not specified | ||||
| 250 | Kyrgyz Republic | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 89370 | 90 | 9.3 | 993 | 9234.9 | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 251 | Republic of Moldova | Global Fund | Aurobindo Pharma Ltd. | Efavirenz | 50mg caps | 0.1537 | 2130 | 30 | 4.61 | 71 | 327.31 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 252 | Republic of Lithuania | Insurance Fund | Лех Ано | Stocrin | Efavirenz | 600mg tab | 2.4687 | 30 | 30 | 74.06 | 1 | 74.06 | 2016 | Yes | Yes | Yes | |||
| 253 | Republic of Poland | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 50mg caps | 0.7247 | 600 | 30 | 21.74 | 20 | 434.8 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 254 | Russian Federation | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 600mg tab | 0.242 | 2123790 | 30 | 7.26 | 70793 | 513957.19 | 2015 | Not specified | Not specified | Not specified | |||
| 255 | Republic of Poland | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 600mg tab | 5.0387 | 6300 | 30 | 151.16 | 210 | 31743.6 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 256 | Republic of Uzbekistan | Global Fund | Strides Arcolab Limited | Efavirenz | Efavirenz | 200mg tab | 0.1033 | 90 | 90 | 9.3 | 1 | 9.3 | 2016 | No | Yes | Yes | |||
| 257 | Republic of Poland | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 600mg tab | 4.8853 | 26100 | 30 | 146.56 | 870 | 127507.2 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 258 | Russian Federation | Government | Pharmasyntez | Regast | Efavirenz | 600mg tab | 0.4353 | 14537700 | 30 | 13.06 | 484590 | 6328745.5 | 2015 | Not specified | Not specified | Not specified | |||
| 259 | Republic of Belarus | Government | Hetero Labs + Фарматех | Efavirenz | 600mg tab | 0.7667 | 1276500 | 30 | 23 | 42550 | 978650 | Republican unitary enterprise "BELPHARMATSIYA" | 2016 | Yes | Yes | Not specified | |||
| 260 | Republic of Tajikistan | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 87480 | 90 | 9.3 | 972 | 9039.6 | UNDP/UNICEF | Not specified | Not specified | Not specified | ||||
| 261 | Republic of Poland | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 200mg tab | 2.9522 | 10800 | 90 | 265.7 | 120 | 31884 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 262 | Republic of Poland | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 600mg tab | 5.85 | 39000 | 30 | 175.5 | 1300 | 228150 | 2015 | Not specified | Not specified | Not specified | |||
| 263 | Republic of Lithuania | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 600mg tab | 2.351 | 30 | 30 | 70.53 | 1 | 70.53 | 2015 | Not specified | Yes | Not specified | |||
| 264 | Russian Federation | Government | Pharmasyntez | Regast | Efavirenz | 600mg tab | 0.3833 | 2173200 | 30 | 11.5 | 72440 | 833060 | 2016 | Yes | Yes | Not specified | |||
| 265 | Republic of Kazakhstan | Government | Merck Sharp & Dohme | Efavirenz | 50mg tab | 0.66 | 69750 | - | - | - | 46035 | 2015 | Not specified | Not specified | Not specified | ||||
| 266 | Kyrgyz Republic | Global Fund | Strides Arcolab Limited | Efavirenz | 600mg tab | 0.3967 | 10590 | 30 | 11.9 | 353 | 4200.7 | UNDP/UNICEF | 2016 | No | No | Not specified | |||
| 267 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Efavirenz | 600mg tab | 0.1167 | 52650 | 30 | 3.5 | 1755 | 6142.5 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 268 | Republic of Moldova | Government | Hetero labs Ltd. | Estiva | Efavirenz | 600mg tab | 0.2503 | 66420 | 30 | 7.51 | 2214 | 16627.14 | Sanfarm-Prim SA | 2015 | Not specified | Not specified | Not specified | ||
| 269 | Republiс of Azerbaijan | Government | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.2588 | 19080 | 90 | 23.29 | 212 | 4937.48 | 2015 | Yes | Yes | Not specified | ||||
| 270 | Republic of Moldova | Global Fund | Aurobindo Pharma Ltd. | Efavirenz | 200mg tab | 0.1436 | 13680 | 90 | 12.92 | 152 | 1963.84 | IDA Foundation | 2016 | Not specified | Not specified | Not specified | |||
| 271 | Republic of Kazakhstan | Government | Zhangjiagang Huachang Pharmaceutical Industry Limited Company, China | Efavirenz | 600mg tab | 0.085 | 379800 | 30 | 2.55 | 12660 | 32283 | 2015 | Not specified | Not specified | Not specified | ||||
| 272 | Republic of Poland | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 200mg tab | 3.2467 | 4500 | 90 | 292.2 | 50 | 14610 | 2015 | Not specified | Not specified | Not specified | |||
| 273 | Republic of Tajikistan | Global Fund | Strides Arcolab Limited | Efavirenz | 600mg tab | 0.1123 | 30 | 30 | 3.37 | 1 | 3.37 | 2015 | Not specified | Not specified | Not specified | ||||
| 274 | Ukraine | Government | Strides Arcolab Limited | Efavirenz | Efavirenz | 200mg tab | 0.1148 | 92520 | 90 | 10.33 | 1028 | 10619.24 | 2016 | Yes | Yes | Yes | |||
| 275 | Republic of Estonia | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 600mg tab | 1.7573 | 30 | 30 | 52.72 | 1 | 52.72 | 2015 | Not specified | Not specified | Not specified | |||
| 276 | Republic of Armenia | Global Fund | Strides Shasun | Efavirenz | 200mg tab | 0.1033 | 3060 | 90 | 9.3 | 34 | 316.2 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 277 | Ukraine | Government | Strides Arcolab Limited | Efavirenz | 600mg tab | 0.1107 | 2127180 | 30 | 3.32 | 70906 | 235407.92 | 2015 | Not specified | Not specified | Not specified | ||||
| 278 | Republic of Armenia | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 2340 | 90 | 9.3 | 26 | 241.8 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | Not specified | Not specified | Not specified | ||
| 279 | Republic of Moldova | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1436 | 13680 | 90 | 12.92 | 152 | 1963.84 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 280 | Russian Federation | Government | ARS Pharm | Efavirenz | Efavirenz | 200mg tab | 0.2497 | 2850 | 30 | 7.49 | 95 | 711.55 | 2015 | Not specified | Not specified | Not specified | |||
| 281 | Georgia | NCDC Georgia | Arcolab LTD | Sustiva | Efavirenz | 600mg tab | 0.0933 | 742500 | 30 | 2.8 | 24750 | 69300 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 282 | Republic of Latvia | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 600mg tab | 1.7223 | 228900 | 30 | 51.67 | 7630 | 394242.09 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 283 | Republic of Uzbekistan | Global Fund | Strides Arcolab Limited | Efavirenz | 600mg tab | 0.1123 | 30 | 30 | 3.37 | 1 | 3.37 | 2015 | Not specified | Not specified | Not specified | ||||
| 284 | Kyrgyz Republic | Global Fund | Strides Arcolab Limited | Efavirenz | 600mg tab | 0.1167 | - | 30 | 3.5 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 285 | Ukraine | Global Fund | Hetero labs Ltd. | Efavirenz | 600mg tab | 0.1023 | 30 | 30 | 3.07 | 1 | 3.07 | 2015 | Not specified | Not specified | Not specified | ||||
| 286 | Republic of Moldova | Global Fund | MYLAN LABORATORIES LTD | Efavirenz | 600mg tab | 0.144 | 15000 | 30 | 4.32 | 500 | 2160 | 2015 | Not specified | Not specified | Not specified | ||||
| 287 | Georgia | Global Fund | Arcolab LTD | Sustiva | Efavirenz | 200mg tab | 0.31 | 4230 | 30 | 9.3 | 141 | 1311.3 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 288 | Georgia | Global Fund | Strides Arcolab Limited | Efavirenz | 600mg tab | 0.1063 | 867960 | 30 | 3.19 | 28932 | 92293.08 | partnership for supply. chain management (PFSCM) | 2015 | No | Not specified | Not specified | |||
| 289 | Republic of Lithuania | Insurance Fund | Merck Sharp & Dohme | Stocrin | Efavirenz | 600mg tab | 2.6127 | 30 | 30 | 78.38 | 1 | 78.38 | 2016 | Yes | Yes | Not specified | |||
| 290 | Republic of Poland | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 200mg tab | 2.9522 | 4500 | 90 | 265.7 | 50 | 13285 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 291 | Russian Federation | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 200mg tab | 0.2229 | 172620 | 90 | 20.06 | 1918 | 38475.08 | 2015 | Not specified | Not specified | Not specified | |||
| 292 | Republic of Tajikistan | Global Fund | Strides Arcolab Limited | Efavirenz | 600mg tab | 0.1097 | 180000 | 30 | 3.29 | 6000 | 19740 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 293 | Republic of Belarus | Government | Hetero Labs + Фарматех | Efavirenz | 600mg tab | 0.7057 | 1276500 | 30 | 21.17 | 42550 | 900783.5 | Фарматех ЗАО | 2015 | Not specified | Not specified | Not specified | |||
| 294 | Republic of Uzbekistan | Global Fund | Strides Arcolab Limited | Efavirenz | Efavirenz | 600mg tab | 0.0562 | 60 | 60 | 3.37 | 1 | 3.37 | 2016 | No | Yes | Yes | |||
| 295 | Republic of Lithuania | Government | Great Britain | Stocrin | Efavirenz | 600mg tab | 2.4883 | 30 | 30 | 74.65 | 1 | 74.65 | Merck Sharp & Dohme Ltd | 2015 | Not specified | Yes | Not specified | ||
| 296 | Russian Federation | Government | Pharmasyntez | Regast | Efavirenz | 100mg tab | 0.064 | 959040 | 30 | 1.92 | 31968 | 61378.56 | 2016 | Yes | Yes | Not specified | |||
| 297 | Ukraine | PEPFAR | Hetero labs Ltd. | Efavirenz | Efavirenz | 600mg tab | 0.0883 | 2063640 | 30 | 2.65 | 68788 | 182288.2 | 2016 | Yes | Yes | Yes | |||
| 298 | Republic of Kazakhstan | Government | Ranbaxy Laboratories Limited | Efavirenz | 600mg tab | 0.084 | 23741100 | 30 | 2.52 | 791370 | 1994252.38 | 2015 | Not specified | Not specified | Not specified | ||||
| 299 | Russian Federation | Government | Pharmasyntez | Regast | Efavirenz | 100mg tab | 0.075 | 227370 | 30 | 2.25 | 7579 | 17052.75 | 2015 | Not specified | Not specified | Not specified | |||
| 300 | Russian Federation | Government | Pharmasyntez | Regast | Efavirenz | 600mg tab | 0.4353 | 14537700 | 30 | 13.06 | 484590 | 6328745.5 | 2015 | Not specified | Not specified | Not specified | |||
| 301 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Efavirenz | 600mg tab | 0.1 | 24870 | 30 | 3 | 829 | 2487 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 302 | Russian Federation | Government | Makizpharma | Efavirenz | Efavirenz | 600mg tab | 0.38 | 1200000 | 30 | 11.4 | 40000 | 456000 | 2016 | Yes | Yes | Not specified | |||
| 303 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Efavirenz | 600mg tab | 0.144 | 30000 | 30 | 4.32 | 1000 | 4320 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 304 | Republic of Kazakhstan | Government | Zhangjiagang Huachang Pharmaceutical Industry Limited Company, China | Efavirenz | 200mg tab | 0.016 | 2624400 | 90 | 1.44 | 29160 | 41990.4 | 2015 | Not specified | Not specified | Not specified | ||||
| 305 | Georgia | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 32400 | 90 | 9.3 | 360 | 3348 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Yes | Not specified | |||
| 306 | Ukraine | Government | Aurobindo Pharma Ltd. | Efavirenz | Efavirenz | 600mg tab | 0.114 | 2127180 | 30 | 3.42 | 70906 | 242498.52 | 2016 | Yes | Yes | Yes | |||
| 307 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Efavirenz | 600mg tab | 0.1167 | 21000 | 30 | 3.5 | 700 | 2450 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 308 | Republic of Moldova | Global Fund | MYLAN LABORATORIES LTD | Efavirenz | 600mg tab | 0.144 | 15000 | 30 | 4.32 | 500 | 2160 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 309 | Republiс of Azerbaijan | Government | Strides Arcolab Limited | Efavirenz | 50mg caps | 0.4467 | 37950 | 30 | 13.4 | 1265 | 16951 | 2015 | Yes | Yes | Not specified | ||||
| 310 | Republic of Poland | Government | Gilead Sciences | Atripla | Efavirenz+Emtricitabin+Tenofovir Disoproxil | 600mg+200mg+245mg tab | 26.436 | 9000 | 30 | 793.08 | 300 | 237924 | 2015 | Not specified | Not specified | Not specified | |||
| 311 | Republic of Poland | Government | Gilead Sciences | Atripla | Efavirenz+Emtricitabin+Tenofovir Disoproxil | 600mg+200mg+245mg tab | 26.436 | 6000 | 30 | 793.08 | 200 | 158616 | 2015 | Not specified | Not specified | Not specified | |||
| 312 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.353 | 87510 | 30 | 10.59 | 2917 | 30891.03 | 2015 | Not specified | Not specified | Not specified | ||||
| 313 | Republic of Tajikistan | Global Fund | Cipla Ltd | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.3167 | 918000 | 30 | 9.5 | 30600 | 290700 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 314 | Kyrgyz Republic | Global Fund | Hetero labs Ltd. | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.375 | 232290 | 30 | 11.25 | 7743 | 87108.75 | UNDP/UNICEF | 2015 | Not specified | Not specified | Not specified | |||
| 315 | Republic of Belarus | Government | Hetero Labs + Фарматех | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 2.8033 | 99000 | 30 | 84.1 | 3300 | 277530 | Фарматех ЗАО | 2015 | Not specified | Not specified | Not specified | |||
| 316 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.353 | 87540 | 30 | 10.59 | 2918 | 30901.62 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 317 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.2663 | 149670 | 30 | 7.99 | 4989 | 39862.11 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 318 | Republic of Poland | Government | Gilead Sciences | Atripla | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 26.436 | 91500 | 30 | 793.08 | 3050 | 2418894 | 2015 | Not specified | Not specified | Not specified | |||
| 319 | Ukraine | Global Fund | Merck Sharp & Dohme | Atripla | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 1 | 2272590 | 30 | 30 | 75753 | 2272590 | 2016 | Yes | Yes | Yes | |||
| 320 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.3247 | 21960 | 30 | 9.74 | 732 | 7129.68 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 321 | Republic of Moldova | Government | Ranbaxy Laboratories Limited | Aviroday ME | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.45 | 430200 | 30 | 13.5 | 14340 | 193590 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Yes | ||
| 322 | Republic of Moldova | Government | Ranbaxy Laboratories Limited | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.591 | 519750 | 30 | 17.73 | 17325 | 307172.25 | Dita Estfarm SRL | Not specified | Not specified | Not specified | ||||
| 323 | Republiс of Azerbaijan | Government | Gilead Sciences | Atripla | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 1.326 | 408960 | 30 | 39.78 | 13632 | 542280.94 | 2015 | Yes | Yes | Not specified | |||
| 324 | Kyrgyz Republic | Global Fund | Hetero labs Ltd. | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.375 | 232290 | 30 | 11.25 | 7743 | 87108.75 | UNDP/UNICEF | 2016 | No | No | Not specified | |||
| 325 | Republic of Uzbekistan | Global Fund | MYLAN LABORATORIES LTD | Efavirenz+Lamivudin+TDF | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.2747 | 30 | 30 | 8.24 | 1 | 8.24 | 2016 | Yes | Yes | Yes | |||
| 326 | Republic of Armenia | Global Fund | Strides Shasun | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.2867 | 108540 | 30 | 8.6 | 3618 | 31114.8 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 327 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.353 | 175050 | 30 | 10.59 | 5835 | 61792.65 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 328 | Ukraine | Government | Hetero labs Ltd. | Trastiva | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.269 | 350460 | 30 | 8.07 | 11682 | 94273.74 | 2016 | Yes | Not specified | Yes | |||
| 329 | Ukraine | Government | Merck Sharp & Dohme | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 1.1637 | 350460 | 30 | 34.91 | 11682 | 407818.62 | 2015 | Not specified | Not specified | Not specified | ||||
| 330 | Republic of Belarus | Government | Hetero Labs + Фарматех | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 3.0667 | 99000 | 30 | 92 | 3300 | 303600 | Republican unitary enterprise "BELPHARMATSIYA" | 2016 | Yes | No | Not specified | |||
| 331 | Ukraine | PEPFAR | Hetero labs Ltd. | Tenofovir | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.218 | 6646020 | 30 | 6.54 | 221534 | 1448832.38 | 2016 | Yes | Yes | Yes | |||
| 332 | Republic of Tajikistan | Global Fund | Hetero labs Ltd. | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 0.375 | 30 | 30 | 11.25 | 1 | 11.25 | 2015 | Not specified | Not specified | Not specified | ||||
| 333 | Ukraine | Global Fund | Merck Sharp & Dohme | Efavirenz+Emtricitabine+Tenofovir - FDC | 600mg+200mg+300mg tab | 1 | 30 | 30 | 30 | 1 | 30 | 2015 | Not specified | Not specified | Not specified | ||||
| 334 | Republic of Poland | Government | Bristol-Myers Squibb | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 29.1667 | 51000 | 30 | 875 | 1700 | 1487500 | 2015 | Not specified | Not specified | Not specified | |||
| 335 | Republic of Poland | Government | Gilead Sciences | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 26.5213 | 96000 | 30 | 795.64 | 3200 | 2546048 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 336 | Republic of Poland | Government | Bristol-Myers Squibb | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 29.1667 | 33000 | 30 | 875 | 1100 | 962500 | 2015 | Not specified | Not specified | Not specified | |||
| 337 | Republic of Poland | Government | Gilead Sciences | Genvoya | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 25.4607 | 228000 | 30 | 763.82 | 7600 | 5805032 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 338 | Republic of Poland | Government | Gilead Sciences | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 25.7257 | 30000 | 30 | 771.77 | 1000 | 771770 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 339 | Republic of Poland | Government | Gilead Sciences | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 26.5213 | 120000 | 30 | 795.64 | 4000 | 3182560 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 340 | Republic of Poland | Government | Gilead Sciences | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 27.319 | 3600 | 30 | 819.57 | 120 | 98348.4 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 341 | Republic of Poland | Government | Bristol-Myers Squibb | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 29.1667 | 75000 | 30 | 875 | 2500 | 2187500 | 2015 | Not specified | Not specified | Not specified | |||
| 342 | Republic of Poland | Government | Gilead Sciences | Emtriva | Emtricitabine | 200mg caps | 7.9727 | 750 | 30 | 239.18 | 25 | 5979.5 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 343 | Republic of Poland | Government | Gilead Sciences | Emtriva | Emtricitabine | 200mg caps | 8.3293 | 2100 | 30 | 249.88 | 70 | 17491.6 | 2015 | Not specified | Not specified | Not specified | |||
| 344 | Russian Federation | Government | Pharmasyntez | Emtritab | Emtricitabine | 200mg tab | 0.19 | 14160 | 30 | 5.7 | 472 | 2690.4 | 2016 | Yes | Yes | Yes | |||
| 345 | Republic of Poland | Government | Gilead Sciences | Emtriva | Emtricitabine | 200mg caps | 8.3293 | 1800 | 30 | 249.88 | 60 | 14992.8 | 2015 | Not specified | Not specified | Not specified | |||
| 346 | Republic of Poland | Government | Gilead Sciences | Emtriva | Emtricitabine | 200mg caps | 9.28 | 1800 | 30 | 278.4 | 60 | 16704 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 347 | Russian Federation | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+300mg+25mg tab | 29.5103 | 20940 | 30 | 885.31 | 698 | 617946.38 | 2015 | Not specified | Not specified | Not specified | |||
| 348 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+300mg+25mg tab | 24.345 | 75000 | 30 | 730.35 | 2500 | 1825875 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 349 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+300mg+25mg tab | 24.345 | 135000 | 30 | 730.35 | 4500 | 3286575 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 350 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+25mg+245mg tab | 26.7733 | 201000 | 30 | 803.2 | 6700 | 5381440 | 2015 | Not specified | Not specified | Not specified | |||
| 351 | Republic of Poland | Government | Gilead Sciences | Odefsey | Emtricitabine+Rilpivirine+Tenofovir | 200mg+25mg+245mg tab | 23.3863 | 159000 | 30 | 701.59 | 5300 | 3718427 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 352 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+25mg+245mg tab | 23.6147 | 102000 | 30 | 708.44 | 3400 | 2408696 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 353 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+25mg+245mg tab | 26.7733 | 73500 | 30 | 803.2 | 2450 | 1967840 | 2015 | Not specified | Not specified | Not specified | |||
| 354 | Republic of Poland | Government | Gilead Sciences | Atripla | Emtricitabine+Rilpivirine+Tenofovir | 200mg+300mg+25mg tab | 24.0383 | 51000 | 30 | 721.15 | 1700 | 1225955 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 355 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+25mg+245mg tab | 26.7733 | 30000 | 30 | 803.2 | 1000 | 803200 | 2015 | Not specified | Not specified | Not specified | |||
| 356 | Republic of Kazakhstan | Government | Gilead Sciences | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.1187 | 7237800 | 30 | 3.56 | 241260 | 858885.62 | 2015 | Not specified | Not specified | Not specified | ||||
| 357 | Ukraine | Global Fund | Macleods Pharmaceuticals Ltd | Тенохоп | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.1787 | 774990 | 30 | 5.36 | 25833 | 138464.88 | 2016 | Yes | Yes | Yes | |||
| 358 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.2233 | 66240 | 30 | 6.7 | 2208 | 14793.6 | IDA Foundation | 2016 | Not specified | Not specified | Not specified | |||
| 359 | Republic of Belarus | Government | Hetero Labs + Фарматех | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 1.2833 | 635220 | 60 | 77 | 10587 | 815199 | 2016 | Not specified | Yes | Not specified | ||||
| 360 | Republic of Poland | Government | Gilead Sciences | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+245mg tab | 17.2693 | 181500 | 30 | 518.08 | 6050 | 3134384 | 2015 | Not specified | Not specified | Not specified | |||
| 361 | Georgia | NCDC Georgia | MYLAN LABORATORIES LTD | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.175 | 246660 | 30 | 5.25 | 8222 | 43165.5 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 362 | Russian Federation | Government | Gilead Sciences | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 6.9733 | 98970 | 30 | 209.2 | 3299 | 690150.81 | 2015 | Not specified | Not specified | Not specified | |||
| 363 | Republic of Tajikistan | Global Fund | Hetero labs Ltd. | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.2003 | 30 | 30 | 6.01 | 1 | 6.01 | 2015 | Not specified | Not specified | Not specified | ||||
| 364 | Republic of Tajikistan | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.179 | 52560 | 30 | 5.37 | 1752 | 9408.24 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 365 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.175 | 79320 | 30 | 5.25 | 2644 | 13881 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 366 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.179 | 20220 | 30 | 5.37 | 674 | 3619.38 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2016-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 367 | Republic of Latvia | Government | Gilead Sciences | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+245mg tab | 15.6427 | 30 | 30 | 469.28 | 1 | 469.28 | 2015 | Not specified | Not specified | Not specified | |||
| 368 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.175 | 86400 | 30 | 5.25 | 2880 | 15120 | partnership for supply. chain management (PFSCM) | 2016 | No | No | Not specified | |||
| 369 | Republic of Belarus | Government | Hetero Labs + Фарматех | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 2.3493 | 317610 | 30 | 70.48 | 10587 | 746171.75 | Фарматех ЗАО | 2015 | Not specified | Not specified | Not specified | |||
| 370 | Georgia | Global Fund | Hetero labs Ltd. | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.1973 | 824040 | 30 | 5.92 | 27468 | 162610.56 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 371 | Republic of Poland | Government | Gilead Sciences | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 15.7033 | 450000 | 30 | 471.1 | 15000 | 7066500 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 372 | Ukraine | Global Fund | Macleods Pharmaceuticals Ltd | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.1787 | 30 | 30 | 5.36 | 1 | 5.36 | 2015 | Not specified | Not specified | Not specified | ||||
| 373 | Republic of Moldova | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.2233 | 33120 | 30 | 6.7 | 1104 | 7396.8 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 374 | Republic of Latvia | Government | Gilead Sciences | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+245mg tab | 17.6727 | 69420 | 30 | 530.18 | 2314 | 1226836.5 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 375 | Republic of Moldova | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.2233 | 33120 | 30 | 6.7 | 1104 | 7396.8 | 2015 | Not specified | Not specified | Not specified | ||||
| 376 | Kyrgyz Republic | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.2003 | - | 30 | 6.01 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 377 | Republic of Poland | Government | Gilead Sciences | Truvada | Emtricitabine/Tenofovir Disoproxil Fumarate | 200mg+300mg tab | 15.703 | 180000 | 30 | 471.09 | 6000 | 2826540 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 378 | Georgia | NCDC Georgia | Arcolab LTD | Truvada | Emtricitabine/Tenofovir Disoproxil Fumarate | 200mg+300mg tab | 0.1667 | 803010 | 30 | 5 | 26767 | 133835 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 379 | Republic of Poland | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 27.75 | 1200 | 60 | 1665 | 20 | 33300 | 2015 | Not specified | Not specified | Not specified | |||
| 380 | Republic of Latvia | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 27.4897 | 840 | 60 | 1649.38 | 14 | 23091.32 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 381 | Russian Federation | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 18.1703 | 26940 | 60 | 1090.22 | 449 | 489508.78 | 2015 | Not specified | Not specified | Not specified | |||
| 382 | Republic of Latvia | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 24.5577 | 60 | 60 | 1473.46 | 1 | 1473.46 | 2015 | Not specified | Not specified | Not specified | |||
| 383 | Republic of Poland | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 26.5615 | 480 | 60 | 1593.69 | 8 | 12749.52 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 384 | Russian Federation | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 16 | 17940 | - | - | - | 287040 | 2016 | Yes | Yes | Not specified | |||
| 385 | Russian Federation | Government | Janssen | Intelence | Etravirine | 200mg tab | 4.5567 | 1136400 | 60 | 273.4 | 18940 | 5178196 | 2016 | Yes | Yes | Yes | |||
| 386 | Ukraine | Government | Janssen | Intelence | Etravirine | 100mg tab | 2.8876 | 23880 | 120 | 346.51 | 199 | 68955.49 | 2016 | Yes | Yes | Yes | |||
| 387 | Republic of Poland | Government | Janssen | Intelence | Etravirine | 200mg tab | 5.902 | 21000 | 60 | 354.12 | 350 | 123942 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Yes | ||
| 388 | Republic of Latvia | Government | Johnson & Johnson | Intelence | Etravirine | 100mg tab | 3.5232 | 120 | 120 | 422.79 | 1 | 422.79 | 2015 | Not specified | Not specified | Not specified | |||
| 389 | Russian Federation | Government | Johnson & Johnson | Intelence | Etravirine | 200mg tab | 5.4245 | 2799660 | 60 | 325.47 | 46661 | 15186756 | 2015 | Not specified | Not specified | Not specified | |||
| 390 | Georgia | Global Fund | Janssen | Etravirine | 100mg tab | 4.7917 | 5760 | 120 | 575 | 48 | 27600 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 391 | Republic of Poland | Government | Janssen | Intelence | Etravirine | 100mg tab | 6.0847 | 21000 | 60 | 365.08 | 350 | 127778 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Yes | ||
| 392 | Ukraine | Government | Janssen | Etravirine | 100mg tab | 2.8922 | 23880 | 120 | 347.06 | 199 | 69064.94 | 2015 | Not specified | Not specified | Not specified | ||||
| 393 | Republic of Poland | Government | Johnson & Johnson | Intelence | Etravirine | 200mg tab | 6.6915 | 18000 | 60 | 401.49 | 300 | 120447 | 2015 | Not specified | Not specified | Not specified | |||
| 394 | Georgia | NCDC Georgia | Janssen | Intelence | Etravirine | 100mg tab | 2.5 | 7080 | 120 | 300 | 59 | 17700 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 395 | Republic of Latvia | Government | Janssen-Cilag Internarional NV | Intelence | Etravirine | 100mg tab | 3.9863 | 3480 | 120 | 478.36 | 29 | 13872.44 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 396 | Russian Federation | Government | Johnson & Johnson | Intelence | Etravirine | 100mg tab | 2.7487 | 454440 | 120 | 329.85 | 3787 | 1249142 | 2015 | Not specified | Not specified | Not specified | |||
| 397 | Republic of Poland | Government | Janssen | Edurant | Etravirine | 100mg tab | 6.0847 | 21000 | 60 | 365.08 | 350 | 127778 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 398 | Republic of Poland | Government | Johnson & Johnson | Intelence | Etravirine | 200mg tab | 6.6915 | 40500 | 60 | 401.49 | 675 | 271005.75 | 2015 | Not specified | Not specified | Not specified | |||
| 399 | Russian Federation | Government | ViiV Healthcare | Telzir | Fosamprenavir | 700mg tab | 2.7 | 628440 | 60 | 162 | 10474 | 1696788 | 2016 | Yes | Yes | Not specified | |||
| 400 | Republic of Latvia | Government | Viiv Healthcare UK Limited | Telzir | Fosamprenavir | 700mg tab | 5.5505 | 2460 | 60 | 333.03 | 41 | 13654.23 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 401 | Russian Federation | Government | ViiV Healthcare | Telzir | Fosamprenavir | 700mg tab | 3.3357 | 2143680 | 60 | 200.14 | 35728 | 7150602 | 2015 | Not specified | Not specified | Not specified | |||
| 402 | Republic of Poland | Government | GlaxoSmithKline | Telzir | Fosamprenavir | 700mg tab | 5.5833 | 1200 | 60 | 335 | 20 | 6700 | Krajowe Centrum ds. AIDS | 2016 | Yes | Not specified | Not specified | ||
| 403 | Republic of Latvia | Government | ViiV Healthcare | Telzir | Fosamprenavir | 700mg tab | 4.8733 | 60 | 60 | 292.4 | 1 | 292.4 | 2015 | Not specified | Not specified | Not specified | |||
| 404 | Russian Federation | Government | ViiV Healthcare | Telzir | Fosamprenavir | 50mg/ml oral solution 225ml | 42.39 | 230 | 1 | 42.39 | 230 | 9749.7 | 2016 | Yes | Yes | Not specified | |||
| 405 | Russian Federation | Government | ViiV Healthcare | Telzir | Fosamprenavir | 50mg/ml oral solution 225ml | 60.21 | 2608 | 1 | 60.21 | 2608 | 157027.69 | 2015 | Not specified | Not specified | Not specified | |||
| 406 | Republic of Poland | Government | GlaxoSmithKline | Telzir | Fosamprenavir | 700mg tab | 5.5833 | 1200 | 60 | 335 | 20 | 6700 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 407 | Georgia | Global Fund | Aurobindo Pharma Ltd. |